Outpatient Pharmacogenomic Screenings to Prevent Addiction, Overdose, and Suicide

by Atmaram Yarlagadda, MD; Kevin Swift, PhD; Nabarun Chakraborty, MS, MBA; Rasha Hammamieh, PhD; Amina Abubakar, PharmD; Marianna Wilbur, PharmD; and Anita H. Clayton, MD Dr. Yarlagadda is Installation Director of Psychological Health at McDonald Army Health Center in Fort Eustis, Virginia. Drs. Swift, Chakraborty, and Hammamieh are with Medical Readiness Systems Biology, Walter Reed [...] The post Outpatient Pharmacogenomic Screenings to Prevent Addiction, Overdose, and Suicide appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Current Issue Original Research addictions CYP2C19 CYP2D6 MDD pain pharmacogenomics Precision medicine PTSD SNP suicides Source Type: research